Table 1.
Characteristics of the sample (n = 430 patients)
| Variable | Level | N = 430 | % |
|---|---|---|---|
| Gender | Male | 332 | 77.2 |
| Female | 98 | 22.8 | |
| Age (years) | Median | 69 | – |
| Std Dev | 10.04 | – | |
| BMI (kg/m2) | Median | 27.85 | – |
| Std Dev | 5.27 | – | |
| Race | White | 404 | 94.0 |
| Black | 14 | 3.3 | |
| Asian | 1 | 0.2 | |
| Native Hawaiian/Pacific Islander | 1 | 0.2 | |
| American Indian/Alaskan | 1 | 0.2 | |
| Unknown/Other | 9 | 2.1 | |
| ASA score | 1 | 3 | 0.7 |
| 2 | 194 | 45.1 | |
| 3 | 224 | 52.1 | |
| 4 | 9 | 2.1 | |
| Anesthesia groups | General only | 215 | 50.0 |
| General + Epidural | 215 | 50.0 | |
| Neoadjuvant chemotherapy | No | 305 | 71.4 |
| Yes | 122 | 28.6 | |
| Unknown | 3 | – | |
| Diversion Type | Ileal conduit | 280 | 65.1 |
| Continent catherizable pouch | 15 | 3.5 | |
| Neobladder | 67 | 15.6 | |
| Cutaneous ureterostomy | 63 | 14.6 | |
| pT stage | T0 | 59 | 13.7 |
| T1 | 44 | 10.2 | |
| T2 | 82 | 19.1 | |
| T3 | 125 | 29.1 | |
| T4 | 62 | 14.4 | |
| Ta/Tis | 58 | 13.5 | |
| pN stage | Nx | 19 | 4.4 |
| N1 | 35 | 8.1 | |
| N2 | 60 | 14.0 | |
| N3 | 17 | 4.0 | |
| N0 | 299 | 69.5 | |
| Radial margin | Negative | 377 | 87.7 |
| Positive | 53 | 12.3 | |
| Ureteral or urethral margin | Negative | 402 | 93.5 |
| Positive | 28 | 6.5 | |
| Grade | High | 350 | 96.7 |
| Low | 5 | 1.4 | |
| Mixed | 2 | 0.6 | |
| Missing | 73 | – | |
| Adjuvant chemotherapy | No | 340 | 79.8 |
| Yes | 86 | 20.2 | |
| Missing | 4 | – | |
| Location of Recurrence | Pelvic | 22 | 16.5 |
| Upper tract | 11 | 8.3 | |
| Distant | 97 | 72.9 | |
| Other | 3 | 2.3 | |
| None | 297 | – |